Enrico Girardi

Author PubWeight™ 108.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Use of a T cell-based assay for monitoring efficacy of antituberculosis therapy. Clin Infect Dis 2004 4.26
2 Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria. Nat Immunol 2011 3.48
3 Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects. Arch Intern Med 2002 2.20
4 Unmasked tuberculosis and tuberculosis immune reconstitution inflammatory disease: a disease spectrum after initiation of antiretroviral therapy. J Infect Dis 2009 2.04
5 Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina. AIDS 2009 1.81
6 Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis 2006 1.80
7 Accuracy of immunodiagnostic tests for active tuberculosis using single and combined results: a multicenter TBNET-Study. PLoS One 2008 1.56
8 Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL? Clin Infect Dis 2010 1.54
9 The Vα14 invariant natural killer T cell TCR forces microbial glycolipids and CD1d into a conserved binding mode. J Exp Med 2010 1.50
10 Late presenters in an HIV surveillance system in Italy during the period 1992-2006. J Acquir Immune Defic Syndr 2008 1.47
11 Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure. AIDS Res Hum Retroviruses 2002 1.45
12 Italian guidelines for the use of antiretroviral agents and the diagnostic-clinical management of HIV-1 infected persons. Update December 2014. New Microbiol 2015 1.45
13 Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study. Respir Res 2007 1.45
14 Galactose-modified iNKT cell agonists stabilized by an induced fit of CD1d prevent tumour metastasis. EMBO J 2011 1.43
15 Upregulation of interferon-induced genes in infants with virus-associated acute bronchiolitis. Exp Biol Med (Maywood) 2007 1.42
16 Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancer. Eur J Cancer 2008 1.33
17 Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcome. Antivir Ther 2011 1.30
18 Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcɛRI. Nat Struct Mol Biol 2011 1.29
19 Selected RD1 peptides for active tuberculosis diagnosis: comparison of a gamma interferon whole-blood enzyme-linked immunosorbent assay and an enzyme-linked immunospot assay. Clin Diagn Lab Immunol 2005 1.29
20 Extensively drug-resistant tuberculosis, Italy and Germany. Emerg Infect Dis 2007 1.29
21 Definition and epidemiology of late presentation in Europe. Antivir Ther 2010 1.23
22 Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med 2014 1.22
23 Cutting edge: structural basis for the recognition of β-linked glycolipid antigens by invariant NKT cells. J Immunol 2011 1.20
24 The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr. Am J Gastroenterol 2007 1.20
25 Is IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons? PLoS One 2010 1.18
26 IP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapy. BMC Infect Dis 2011 1.12
27 Soluble CD23 monomers inhibit and oligomers stimulate IGE synthesis in human B cells. J Biol Chem 2007 1.12
28 IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis. J Infect 2013 1.10
29 HVR-1 quasispecies modifications occur early and are correlated to initial but not sustained response in HCV-infected patients treated with pegylated- or standard-interferon and ribavirin. J Hepatol 2004 1.08
30 Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition. Clin Infect Dis 2011 1.07
31 Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis. Mol Med 2003 1.06
32 Glycolipids that elicit IFN-γ-biased responses from natural killer T cells. Chem Biol 2011 1.05
33 New tools for detecting latent tuberculosis infection: evaluation of RD1-specific long-term response. BMC Infect Dis 2009 1.05
34 IP-10 detection in urine is associated with lung diseases. BMC Infect Dis 2010 1.05
35 IFN-gamma, but not IP-10, MCP-2 or IL-2 response to RD1 selected peptides associates to active tuberculosis. J Infect 2010 1.04
36 NKT cell ligand recognition logic: molecular basis for a synaptic duet and transmission of inflammatory effectors. J Immunol 2011 1.04
37 Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals. Clin Infect Dis 2005 1.04
38 Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study. BMC Infect Dis 2008 1.03
39 Simple and reliable method for detection and genotyping of hepatitis C virus RNA in dried blood spots stored at room temperature. J Clin Microbiol 2002 1.01
40 Effective highly active antiretroviral therapy in patients with primary HIV-1 infection prevents the evolution of the avidity of HIV-1-specific antibodies. J Acquir Immune Defic Syndr 2007 1.01
41 Behavioral correlates of adherence to antiretroviral therapy. J Acquir Immune Defic Syndr 2002 1.01
42 Methylated HBHA produced in M. smegmatis discriminates between active and non-active tuberculosis disease among RD1-responders. PLoS One 2011 1.01
43 Implications of storing urinary DNA from different populations for molecular analyses. PLoS One 2009 1.00
44 Detection of Pulmonary tuberculosis: comparing MR imaging with HRCT. BMC Infect Dis 2011 1.00
45 Tuberculosis transmission between foreign- and native-born populations in the EU/EEA: a systematic review. Eur Respir J 2013 0.98
46 Structural basis for the recognition of C20:2-αGalCer by the invariant natural killer T cell receptor-like antibody L363. J Biol Chem 2011 0.97
47 How many people are living with undiagnosed HIV infection? An estimate for Italy, based on surveillance data. AIDS 2016 0.97
48 Risk of tuberculosis following HIV seroconversion in high-income countries. Thorax 2012 0.96
49 Specific T cells restore the autophagic flux inhibited by Mycobacterium tuberculosis in human primary macrophages. J Infect Dis 2012 0.96
50 Comparison of LCx with other current viral load assays for detecting and quantifying human immunodeficiency virus type 1 RNA in patients infected with the circulating recombinant form A/G (CRF02). J Clin Microbiol 2004 0.96
51 Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02). J Acquir Immune Defic Syndr 2002 0.96
52 Access to antiretroviral treatment, incidence of sustained therapy interruptions, and risk of clinical events according to sex: evidence from the I.Co.N.A. Study. J Acquir Immune Defic Syndr 2003 0.95
53 Impact of hepatitis C virus infection on lifestyle. World J Gastroenterol 2007 0.95
54 Higher frequency of T-cell response to M. tuberculosis latency antigen Rv2628 at the site of active tuberculosis disease than in peripheral blood. PLoS One 2011 0.95
55 IP-10 is an additional marker for tuberculosis (TB) detection in HIV-infected persons in a low-TB endemic country. J Infect 2012 0.93
56 Expression levels of TLRs involved in viral recognition in PBMCs from HIV-1-infected patients failing antiretroviral therapy. Intervirology 2009 0.92
57 Structure of the uncomplexed Neisseria meningitidis factor H-binding protein fHbp (rLP2086). Acta Crystallogr Sect F Struct Biol Cryst Commun 2011 0.92
58 Hepatitis E virus genotype 4 outbreak, Italy, 2011. Emerg Infect Dis 2013 0.92
59 Monophyletic HIV type 1 CRF02-AG in a nosocomial outbreak in Benghazi, Libya. AIDS Res Hum Retroviruses 2002 0.92
60 Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results. Clin Infect Dis 2008 0.92
61 Monophyletic outbreak of Hepatitis A involving HIV-infected men who have sex with men, Rome, Italy 2008-2009. J Clin Virol 2012 0.92
62 Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs. BMC Infect Dis 2009 0.92
63 Gene expression of nucleic acid-sensing pattern recognition receptors in children hospitalized for respiratory syncytial virus-associated acute bronchiolitis. Clin Vaccine Immunol 2009 0.91
64 A toolbox for tuberculosis diagnosis: an Indian multicentric study (2006-2008): microbiological results. PLoS One 2012 0.90
65 HIV incidence estimate combining HIV/AIDS surveillance, testing history information and HIV test to identify recent infections in Lazio, Italy. BMC Infect Dis 2012 0.90
66 Serial QuantiFERON TB-gold in-tube testing during LTBI therapy in candidates for TNFi treatment. J Infect 2012 0.89
67 A toolbox for tuberculosis (TB) diagnosis: an Indian multicentric study (2006-2008). Evaluation of QuantiFERON-TB gold in tube for TB diagnosis. PLoS One 2013 0.89
68 Response to HAART and GB virus type C coinfection in a cohort of antiretroviral-naive HIV-infected individuals. Antivir Ther 2005 0.89
69 Helicobacter pylori cholesteryl α-glucosides contribute to its pathogenicity and immune response by natural killer T cells. PLoS One 2013 0.88
70 The potential impact of routine testing of individuals with HIV indicator diseases in order to prevent late HIV diagnosis. BMC Infect Dis 2013 0.88
71 T cell responses to commercial mycobacterium tuberculosis-specific antigens in HIV-infected patients. Clin Infect Dis 2007 0.87
72 Atomic structure of the autosomal recessive hypercholesterolemia phosphotyrosine-binding domain in complex with the LDL-receptor tail. Proc Natl Acad Sci U S A 2012 0.86
73 Structural and functional characterization of a novel nonglycosidic type I NKT agonist with immunomodulatory properties. J Immunol 2012 0.86
74 'Sentinel' mutations in standard population sequencing can predict the presence of HIV-1 reverse transcriptase major mutations detectable only by ultra-deep pyrosequencing. J Antimicrob Chemother 2011 0.85
75 Evolution of HVR-1 quasispecies after 1-year treatment in HIV/HCV-coinfected patients according to the pattern of response to highly active antiretroviral therapy. Antivir Ther 2006 0.84
76 Consent policies and rates of HIV testing. JAMA 2007 0.84
77 Strengthening tuberculosis diagnosis in a low-resource setting: experience learned in Dodoma, Tanzania. J Infect Dev Ctries 2013 0.84
78 HIV-Infected Late Presenter Patients. AIDS Res Treat 2011 0.83
79 Short- and long-term mortality and causes of death in HIV/tuberculosis patients in Europe. Eur Respir J 2013 0.83
80 Tuberculosis case finding based on symptom screening among immigrants, refugees and asylum seekers in Rome. BMC Public Health 2013 0.83
81 Pregnancy outcomes among ART-naive and ART-experienced HIV-positive women: data from the ICONA foundation study group, years 1997-2013. J Acquir Immune Defic Syndr 2014 0.82
82 Characteristics and behaviors in a sample of patients unaware of their infection until AIDS diagnosis in Italy: a cross-sectional study. AIDS Care 2011 0.82
83 Retrospective investigation of an influenza A/H1N1pdm outbreak in an Italian military ship cruising in the Mediterranean Sea, May-September 2009. PLoS One 2011 0.82
84 Epidemiological aspects of major opportunistic infections of the respiratory tract in persons with AIDS: Europe, 1993-2000. AIDS 2003 0.82
85 Cystic echinococcosis in a single tertiary care center in Rome, Italy. Biomed Res Int 2013 0.81
86 HIV-1 DNA burden dynamics in CD4 T cells and monocytes in patients undergoing a transient therapy interruption. J Med Virol 2004 0.81
87 Thymidine kinase and deoxycytidine kinase activity in mononuclear cells from antiretroviral-naive HIV-infected patients. AIDS 2005 0.81
88 Lack of implementation of Hepatitis B Virus (HBV) vaccination policy in household contacts of HBV carriers in Italy. BMC Infect Dis 2009 0.81
89 Human neutrophil peptides stimulate tumor necrosis factor-alpha release by alveolar macrophages from patients with sarcoidosis. Chest 2009 0.81
90 Pharmacodynamics of interferon beta in multiple sclerosis patients with or without serum neutralizing antibodies. J Neurol 2007 0.80
91 Using a database of HIV patients undergoing genotypic resistance test after HAART failure to understand the dynamics of M184V mutation. Antivir Ther 2003 0.80
92 Structural modifications induced by specific HIV-1 protease-compensatory mutations have an impact on the virological response to a first-line lopinavir/ritonavir-containing regimen. J Antimicrob Chemother 2013 0.78
93 Improvement of tuberculosis laboratory capacity on Pemba Island, Zanzibar: a health cooperation project. PLoS One 2012 0.78
94 [Time trends in infectious disease mortality in Italy: 1969-1999]. Epidemiol Prev 2005 0.78
95 Possible child-to-mother transmission of HIV by breastfeeding. JAMA 2005 0.77
96 Age and prediction of sustained virological response to hepatitis C virus (HCV) infection treatment based on 28-day decrease in HCV RNA levels. J Infect Dis 2009 0.77
97 Chronic hepatitis C in Italy: the vanishing of the first and most consistent epidemic wave. Dig Liver Dis 2013 0.77
98 Cavitary pulmonary tuberculosis HIV-related. Eur J Radiol 2004 0.77
99 Triple therapy for hepatitis C improves viral response but also increases the risk of severe infections and anaemia: a frequentist meta-analysis approach. New Microbiol 2014 0.76
100 The combination of a smoking cessation programme with rehabilitation increases stop-smoking rate. J Rehabil Med 2008 0.76
101 Access to treatment for HBV infection and its consistency with 2008 European guidelines in a multicentre cross-sectional study of HIV/HBV co-infected patients in Italy. BMC Res Notes 2013 0.75
102 Should individuals who are tuberculin skin test negative and positive to RD1-IFN-gamma assay receive preventive therapy? Am J Respir Crit Care Med 2007 0.75
103 Effect of hepatitis C virus genotype on CD4+ T cell count in a cohort of antiretroviral-naive HIV-1-infected individuals. J Infect Dis 2005 0.75
104 Percentage and determinants of missed HIV testing in pregnancy: a survey of women delivering in the Lazio region, Italy. AIDS Care 2013 0.75
105 Temporal trend and characteristics of recent HIV-1 infections: application of an algorithm for the identification of recently acquired HIV-1 infections among newly diagnosed individuals over a 10-year period. New Microbiol 2013 0.75
106 Partnership of HIV-infected women and health status. J Acquir Immune Defic Syndr 2005 0.75
107 HIV self-testing in Italy. J Acquir Immune Defic Syndr 2017 0.75
108 The 2005 Italian Quality Control Study for the evaluation of CD4 cells in centers involved in the treatment of HIV type 1 patients. AIDS Res Hum Retroviruses 2007 0.75
109 Drop in CD4+ counts below 200 cells/µL after reaching (or starting from) values higher than 350 cells/µL in HIV-infected patients with virological suppression. J Acquir Immune Defic Syndr 2017 0.75
110 Corrigendum: NANS-mediated synthesis of sialic acid is required for brain and skeletal development. Nat Genet 2017 0.75